title: A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
abstract: OBJECTIVE
  Standardizing body surface area (BSA) determination is essential for avoiding variation in chemotherapy dosage calculations. In this study, we compared variation in BSA calculation using weight and height by the Mosteller formula with weight alone using recently adapted table at a local oncology center.
  
  
  METHODS
  Cross-sectional study of pediatric oncology patients presenting to a pediatric oncology clinic over a week period of time.
  
  
  RESULTS
  One-hundred consecutive pediatric oncology patients presented to the clinic. The mean BSA calculated by the Mosteller formula was 0.83 m(2) (SD 0.24) and the mean BSA determined by the table (based on weight alone) was 0.82 m(2) (SD 0.25). The mean variation in dosing between the two methods was 1.64% (SD 3.4). Only 13 out of 100 patients (13%) had equal dosing using both methods and 21 out of 100 patients (21%) had dosing variation greater than 5%. When comparing both methods, using paired t-test, the difference was statistically significant (t((99)) = 3.99 and p < 0.001).
  
  
  CONCLUSIONS
  Significant differences in BSAbased chemotherapy dosing exist in our center. The Mosteller method should remain the standard until prospective studies are performed to determine the significance of this dosing variability on toxicity and survival outcome.
authors.affiliation: Princess Norah Oncology Center, King Abdul Aziz Medical City, Jeddah, Saudi Arabia.
authors.forename: Wasil
authors.initials: W
authors.lastname: Jastaniah
authors.forename: Mohammed
authors.initials: M
authors.lastname: Aseeri
mesh_terms: D000465:Algorithms; D000886:Anthropometry; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001830:Body Surface Area; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents